Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEART2D: Postprandial vs Fasting Insulin in T2DM Post-MI
NCT00191282Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2002
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
Phase 4, randomised, open-label trial of insulin lispro in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Major Adverse Cardiovascular Events at 5.5 years. Started Oct 2002; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00191282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191282.